Australia TGA ARTG recordClinical chemistry hormone IVDs
Australia TGA ARTG Registered Device · Revvity Pty Ltd · Sero AS · Class IIb · Started June 06, 2012
Good Name: Revvity Pty Ltd - Clinical chemistry hormone IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- Start Date
- June 06, 2012
- Effective Date
- June 06, 2012
- Name
- Revvity Pty Ltd
- Name
- Sero AS
- Country
- Norway
- Address
- Stasjonsveien 44, Billingstad, N-1396
IVDs that are intended to be used for the qualitative and/or quantitative determination of clinical chemistry hormones in a clinical specimen.
Access comprehensive regulatory information for Clinical chemistry hormone IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Revvity Pty Ltd, manufactured by Sero AS in Norway. The device registration started on June 06, 2012.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.